MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.830
0.000
0.00%
Closed 16:00 01/17 EST
OPEN
1.900
PREV CLOSE
1.830
HIGH
1.900
LOW
1.830
VOLUME
1.18K
TURNOVER
--
52 WEEK HIGH
2.978
52 WEEK LOW
1.443
MARKET CAP
21.16M
P/E (TTM)
-6.7453
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PRPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

PRPH News

  • We're Hopeful That ProPhase Labs (NASDAQ:PRPH) Will Use Its Cash Wisely
  • Simply Wall St..01/09 16:31
  • ProPhase Labs Reports $0.25/Share Special Dividend
  • Benzinga.11/20/2019 21:15
  • PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND
  • GlobeNewswire.11/20/2019 21:15
  • ProPhase Labs reports Q3 results
  • seekingalpha.11/12/2019 19:36

More

Industry

Food Processing
+0.20%
Food & Tobacco
+0.04%

Hot Stocks

Name
Price
%Change

About PRPH

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
More

Webull offers ProPhase Labs Inc (PRPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.